- 24 h
- 7 Tage
- 14 Tage
- 6 Monate
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 00:50 | Algorae Pharmaceuticals Identifies 90 New Drug-Combination Candidates from AlgoraeOS V2 Analysis | 1 | smallcaps.com.au | ||
| 00:35 | LIR Life Sciences reicht provisorische Patentanmeldung für die nadelfreie Verabreichung von GLP/GIP-basierten Adipositastherapien ein | 149 | IR-WORLD | Vancouver, Kanada - 11. Dezember 2025 / IRW-Press / LIR Life Sciences Corp. (CSE: SKNY) (FWB: N790, WKN: A41QA9) ("LIR" oder das "Unternehmen") gibt bekannt, dass es eine
provisorische Patentanmeldung... ► Artikel lesen | |
| 00:33 | JW THERAP-B (02126): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 2 | HKEx | ||
| 00:30 | FDA approves Amgen's UPLIZNA for generalized myasthenia gravis | 2 | Investing.com | ||
| 00:30 | Mesoblast Limited: Independent Study Presented at American Society of Hematology (ASH) Annual Meeting Concludes Remestemcel-L Superior to Ruxolitinib in Clinical Outcomes as Treatment for SR-aGvHD | 1 | GlobeNewswire (USA) | ||
| 00:30 | ASEP Medical Holdings Inc (2): Asep Medical amends 2024 MD&A | 4 | Stockwatch | ||
| 00:29 | JW THERAP-B (02126): (1) APPOINTMENT OF CHIEF EXECUTIVE OFFICER AND EXECUTIVE DIRECTOR; (2) APPOINTMENT OF CHAIRMAN OF THE BOARD; (3) RESIGNATION OF CHIEF ... | 1 | HKEx | ||
| 00:24 | Cycle Pharmaceuticals acquiring Applied Therapeutics | 2 | Seeking Alpha | ||
| 00:06 | Hemostemix Inc (2): Hemostemix grants options to buy 963,000 shares | 1 | Stockwatch | ||
| 00:02 | MESOBLAST LIMITED: Study at ASH Concludes Remestemcel-L Superiority in SR-aGvHD | - | ASX | ||
| 00:02 | Lir Life Sciences Corp.: LIR Life Sciences Files Provisional Patent Application for Needle-Free Delivery of GLP/GIP-Based Obesity Therapies | 161 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / December 11, 2025 / LIR Life Sciences Corp. (CSE:SKNY)(Frankfurt:N790, WKN: A41QA9) ("LIR" or the "Company") announces that it has filed a provisional patent application... ► Artikel lesen | |
| Do | Scilex Holding: Aktionäre genehmigen Neufestsetzung der Ausübungspreise von Aktienoptionen | 2 | Investing.com Deutsch | ||
| Do | Rein Therapeutics beendet Finanzierungsvereinbarungen mit Yorkville ohne Strafzahlungen | 3 | Investing.com Deutsch | ||
| Do | Terns Pharmaceuticals nimmt 747,5 Millionen US-Dollar durch öffentliche Platzierung ein | 1 | Investing.com Deutsch | ||
| Do | Contineum Therapeutics startet Aktienemission im Wert von 75 Millionen US-Dollar | 1 | Investing.com Deutsch | ||
| Do | Cycle Pharmaceuticals to Acquire Applied Therapeutics | 1 | GlobeNewswire (USA) | ||
| Do | Contineum Therapeutics launches $75 million public offering of stock | 1 | Investing.com | ||
| Do | OPTHEA LIMITED: Notice of Market Update | - | ASX | ||
| Do | Microbix Biosystems Inc.: Microbix Schedules Release of Results for Q4 Fiscal 2025 | 1 | GlobeNewswire (USA) | ||
| Do | Raymond James initiates Phathom Pharmaceuticals stock with Strong Buy rating | 3 | Investing.com |
1 2 3 4 5 Weiter >>
- 24 h
- 7 Tage
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| EVOTEC | 12 | 44 | -0,04 % | DAX-Check LIVE: Aurubis, Evotec, Formycon, Infineon, Porsche SE, Siemens Energy im Fokus | Die Erholung an der Börse hat sich zur Wochenmitte nicht fortgesetzt. Der DAX startete zwar mit kleinen Gewinnen in den Tag, rutschte im Verlauf jedoch ins Minus und schloss schließlich bei 23.694 Punkten... ► Artikel lesen | ||
| AC IMMUNE | 9 | - | +14,47 % | XFRA IMR: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILAC IMMUNE SA SF-... ► Artikel lesen | ||
| BIONTECH | 8 | 13 | -0,06 % | Arrowhead, BioNTech, Madrigal & Co: Biotech-Power für das Depot! | Das Börsenjahr 2025 stand natürlich ganz klar im Schatten der US-Technologieriesen wie Nvidia & Co. Darüber hinaus sorgten auch die Gold- und Silberaktien für Aufsehen, doch eine stark laufende Branche... ► Artikel lesen | ||
| RHYTHM PHARMACEUTICALS | 8 | 3 | +12,85 % | Rhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals Announces Preliminary Data from Exploratory Phase 2 Trial that showed Setmelanotide Demonstrated Positive Efficacy Signal in Prader-Willi Syndrome | - - BMI and hyperphagia reductions have been observed in patients with PWS treated with setmelanotide at Month 3 (n=8) and Month 6 (n=5); 17 of 18 enrolled patients remain on therapy -- -- Promising... ► Artikel lesen | ||
| TENAYA THERAPEUTICS | 8 | - | 0,00 % | Tenaya Therapeutics, Inc.: Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC | |||
| KYMERA THERAPEUTICS | 7 | 6 | -2,31 % | Kymera Therapeutics, Inc.: Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Atopic Dermatitis | Fast Track designation supported by positive results from the KT-621 BroADen Phase 1b atopic dermatitis (AD) patient trial KT-621 BROADEN2 Phase 2b AD trial ongoing, with data expected to be reported... ► Artikel lesen | ||
| REZOLUTE | 7 | - | -87,34 % | Xoma Crumbles And Partner Rezolute Collapses On Failed Insulin Disease Drug | |||
| XOMA ROYALTY | 5 | 2 | -22,97 % | XOMA Royalty Corporation: XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc | EMERYVILLE, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation ("XOMA Royalty") (Nasdaq: XOMA), the biotech royalty aggregator, today announced it has successfully completed its previously... ► Artikel lesen | ||
| MODERNA | 4 | 16 | +1,55 % | Nanexa AB: Nanexa and Moderna enter into license and option agreement for the development of PharmaShell-based products | The agreement covers the development of up to five undisclosed compounds. Nanexa will receive an upfront payment of USD 3 million and is entitled to up to USD 500 million in potential milestone payments... ► Artikel lesen | ||
| VALNEVA | 4 | 5 | -0,57 % | Rheinmetall Aktie: Heiß! - Dt. Börse, Heidelberger Druck, Mutares, Steyr und Valneva im Marktbericht Börse Frankfurt | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen |
- Alle
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| BIO-GATE AG | 0,855 | 3 | +251 % | 1 | 1 | - | |||
| NANOREPRO AG | 1,535 | 4,50 | +193 % | 1 | - | - | |||
| MARINOMED BIOTECH AG | 19,000 | 51 | +168 % | 1 | - | - | |||
| EVOTEC SE | 5,240 | 8 | +53 % | 2 | 2 | - | |||
| BIONTECH SE ADR | 81,85 | 121,08 | +48 % | 6 | 1 | - | |||
| QIAGEN NV | 38,605 | 46 | +19 % | 7 | 1 | - | |||
| SARTORIUS STEDIM BIOTECH SA | 208,00 | 237,50 | +14 % | 6 | 1 | - |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .